表紙
市場調查報告書

經皮藥物輸送設備:醫療設備的開發平台評估

Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020

出版商 GlobalData 商品編碼 851181
出版日期 內容資訊 英文 380 Pages
訂單完成後即時交付
價格
經皮藥物輸送設備:醫療設備的開發平台評估 Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020
出版日期: 2020年10月31日內容資訊: 英文 380 Pages
簡介

本報告提供全球經皮藥物遞送設備市場上的主要開發中產品 (醫療設備) 及其臨床實驗的進展調查,再彙整產品的功能·特性比較分析 (臨床實驗的各進展階段) ,以及主要企業簡介及代表性產品,近來的市場動靜 (業績報告·資本交易趨勢等) 等資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 經皮藥物輸送設備概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各領域
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 經皮藥物輸送設備的企業:各臨床實驗階段的開發中產品
  • 經皮藥物輸送設備:各臨床實驗階段的開發中產品

第5章 經皮藥物輸送設備市場:企業·產品概要

  • 3M Co
  • 4P Therapeutics LLC
  • Actuated Medical Inc
  • Aequus Pharmaceuticals Inc
  • Agile Therapeutics Inc
  • Allergan Plc
  • Alliqua BioMedical Inc
  • AMW GmbH
  • AngioSoma Inc
  • Apogee Technology Inc
  • 旭化成製藥
  • AstraZeneca Plc
  • Avro Life Sciences
  • Boryung Pharmaceutical Co Ltd
  • Burke Pharmaceuticals LLC
  • Cassava Sciences Inc
  • CB Scientific Inc
  • Cerimon Pharmaceuticals, Inc. (Inactive)
  • ChemioCare USA Inc
  • Chrono Therapeutics Inc
  • Cipla Ltd
  • Clexio Biosciences Ltd
  • Corium International Inc
  • Daewoong Pharmaceutical Co Ltd
  • DBV Technologies SA
  • DD Therapeutics LLC
  • Dermisonics Inc (Inactive)
  • Dharma Therapeutics, Inc. (Inactive)
  • Drexel University
  • DURECT Corp
  • Echo Therapeutics Inc
  • Emplicure AB
  • Endo International Plc
  • Extend Biosciences Inc
  • Fe3 Medical Inc
  • Georgia Institute of Technology
  • Georgia State University
  • 久光製藥
  • I.M. Sechenov Moscow State Medical University
  • Icure Pharmaceutical Inc
  • ImmuPatch
  • Indian Institute of Science
  • Indian Institute of Technology Bombay
  • InMed Pharmaceuticals Inc
  • Institute of Materials Research & Engineering
  • Intercell AG (Inactive)
  • Interstitial NS
  • Isis Biopolymer Inc (Inactive)
  • Janisys
  • KTH Royal Institute of Technology
  • LEO Pharma A/S
  • Lohmann Therapie-Systeme AG
  • Luye Pharma Group Ltd
  • Massachusetts Institute of Technology
  • Mayne Pharma Group Ltd
  • Medherant Ltd
  • Medifron DBT Inc
  • MEDRx Co Ltd
  • MedRx, Inc.
  • Microdermics Inc
  • Micron Biomedical Inc
  • Micropoint Technologies Pte Ltd
  • National University of Singapore
  • Nemaura Pharma Ltd
  • NeuroDerm Ltd
  • 日東電工
  • North Carolina State University
  • Noven Pharmaceuticals Inc
  • NutriBand Inc
  • Nuvo Pharmaceuticals Inc
  • Phosphagenics Ltd
  • Prometheon Pharma LLC
  • Purdue University
  • Radius Health Inc
  • Scilex Ltd
  • Seelos Therapeutics Inc
  • Shenox Pharmaceuticals LLC
  • Sinsin Pharmaceutical Co Ltd
  • Skinject Inc
  • Sparsha Pharma International Pvt Ltd
  • Sparsha Pharma USA Inc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Stanford University
  • 大日本住友製藥
  • Syntropharma Ltd
  • Taho Pharmaceuticals Ltd
  • Teikoku Pharma USA Inc
  • tesa Labtec GmbH
  • Teva Pharmaceutical Industries Ltd
  • The Sheikh Zayed Institute for Pediatric Surgical Innovation
  • TheraJect Inc
  • Therapeutic Systems Research Laboratories Inc
  • TheraSolve NV
  • Theratech, Inc.
  • Thrudermic LLC
  • Titan Pharmaceuticals Inc
  • toaeiyo
  • Transcu Group Limited (Inactive)
  • Transdermal Delivery Solutions Corp
  • Transdermal Specialties Inc
  • TransPharma Medical Ltd (Inactive)
  • Transport Pharmaceuticals Inc
  • Univec, Inc. (Inactive)
  • University of Illinois at Chicago
  • University of North Carolina at Chapel Hill School of Medicine
  • University of Toronto
  • ViiV Healthcare UK Ltd
  • Vyteris, Inc. (Inactive)
  • Xel Pharmaceuticals Inc
  • Zambon Italia Srl
  • Z-Cube Srl
  • ZetrOZ, Inc.
  • Zosano Pharma Corp
  • Zynerba Pharmaceuticals Inc

第6章 經皮藥物輸送設備市場:目前的趨勢 (全10件)

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME1018EPD

GlobalData's Medical Devices sector report, "Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Transdermal Drug Delivery Devicess pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Transdermal Drug Delivery Devices is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Transdermal Drug Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transdermal Drug Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transdermal Drug Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Transdermal Drug Delivery Overview

3 Products under Development

  • 3.1 Transdermal Drug Delivery - Pipeline Products by Stage of Development
  • 3.2 Transdermal Drug Delivery - Pipeline Products by Segment
  • 3.3 Transdermal Drug Delivery - Pipeline Products by Territory
  • 3.4 Transdermal Drug Delivery - Pipeline Products by Regulatory Path
  • 3.5 Transdermal Drug Delivery - Pipeline Products by Estimated Approval Date
  • 3.6 Transdermal Drug Delivery - Ongoing Clinical Trials

4 Transdermal Drug Delivery - Pipeline Products under Development by Companies

  • 4.1 Transdermal Drug Delivery Companies - Pipeline Products by Stage of Development
  • 4.2 Transdermal Drug Delivery - Pipeline Products by Stage of Development

5 Transdermal Drug Delivery Companies and Product Overview

6 Transdermal Drug Delivery- Recent Developments 2977 Appendix

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us

List of Tables

List of Tables

  • Table 1: Transdermal Drug Delivery - Pipeline Products by Stage of Development
  • Table 2: Transdermal Drug Delivery - Pipeline Products by Segment
  • Table 3: Transdermal Drug Delivery - Pipeline Products by Territory
  • Table 4: Transdermal Drug D

List of Figures

List of Figures

  • Figure 1: Transdermal Drug Delivery - Pipeline Products by Stage of Development
  • Figure 2: Transdermal Drug Delivery - Pipeline Products by Segment
  • Figure 3: Transdermal Drug Delivery - Pipeline Products by Territory
  • Figure 4: Transdermal Drug Delivery - Pipeline Products by Regulatory Path
  • Figure 5: Transdermal Drug Delivery - Pipeline Products by Estimated Approval Date
  • Figure 6: Transdermal Drug Delivery - Ongoing Clinical Trials